OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53
Hany A. Omar(Beni-Suef University), Taleb H. Al‐Tel(University of Sharjah)
Cited by 30
Related Papers
Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis
|PLoS ONE|2016|132
OSU-CG5, a novel energy restriction mimetic agent, targets human colorectal cancer cells in vitro
|Acta Pharmacologica Sinica|2014|35
Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins
|Scientific Reports|2020|28
Discovery of Novel Class of Histone Deacetylase Inhibitors as Anticancer Agents
|Research Square|2021|0